Chronic Lymphocytic Leukemia Clinical Trial

Efficacy and Safety of Idelalisib in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia

Summary

The primary objective of this study is to evaluate the effect of the addition of idelalisib to ofatumumab on progression-free survival (PFS) in participants with previously treated leukemia-cll/" >chronic lymphocytic leukemia (CLL).

View Eligibility Criteria

Eligibility Criteria

Key Inclusion Criteria:

Adults with previously treated recurrent CLL who have measurable lymphadenopathy
Require therapy for CLL
Have experienced CLL progression < 24 months since the completion of the last prior therapy
Have disease that is not refractory to ofatumumab

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Study is for people with:

Chronic Lymphocytic Leukemia

Phase:

Phase 3

Estimated Enrollment:

261

Study ID:

NCT01659021

Recruitment Status:

Terminated

Sponsor:

Gilead Sciences

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 78 Locations for this study

See Locations Near You

City of Hope
Duarte California, 91010, United States
California Cancer Associates for Research and Excellence (CCARE)
Fresno California, 93720, United States
Kaiser Permanente
San Diego California, 92120, United States
Coastal Integrative Cancer Care
San Luis Obispo California, 93401, United States
Stanford University Medical Center
Stanford California, 94305, United States
Kaiser Permanente Vallejo Medical Center
Vallejo California, 94589, United States
Kaiser Permanente of Colorado
Denver Colorado, 80205, United States
Saint Mary's Regional Cancer Center
Grand Junction Colorado, 81501, United States
Cancer Specialists of North Florida
Jacksonville Florida, 32256, United States
Georgia Regents University
Augusta Georgia, 30912, United States
Montgomery Cancer Center
Mount Sterling Kentucky, 40353, United States
Center for Cancer and Blood Disorders, PC
Bethesda Maryland, 20817, United States
Dana Farber Cancer Institute
Boston Massachusetts, 02215, United States
Washington University Medical Center
Saint Louis Missouri, 63110, United States
Comprehensive Cancer Centers of Nevada
Las Vegas Nevada, 89169, United States
Weill Cornell Medical Center
New York New York, 10065, United States
Oncology Hematology Care, Inc.
Cincinnati Ohio, 45242, United States
The Ohio State University Medical Center
Columbus Ohio, 43202, United States
Oregon Health and Science University
Portland Oregon, 97239, United States
Upstate Oncology Associates
Greenville South Carolina, 29601, United States
Tennessee Oncology, PLLC
Chattanooga Tennessee, 37404, United States
Tenessee Oncology, PLLC
Nashville Tennessee, 37203, United States
Utah Cancer Specialists
Salt Lake City Utah, 84106, United States
Northwest Medical Specialties
Tacoma Washington, 98405, United States
Saint George and Sutherland Hospitals
Kogarah New South Wales, 2217, Australia
Prince of Wales Hospital
Randwick New South Wales, 2031, Australia
Westmead Hospital
Westmead New South Wales, 2145, Australia
Royal Brisbane and Women's Hospital
Herston Queensland, 4029, Australia
Haematology and Oncology Clinics of Australia at Mater
Milton Queensland, 4064, Australia
Ashford Cancer Centre Research
Ashford South Australia, 5035, Australia
Box Hill Hospital
Box Hill Victoria, 3128, Australia
Frankston Hospital
Melbourne Victoria, 3199, Australia
Queen Elizabeth Hospital
Woodville , 5011, Australia
Ziekenhuis Netwerk Antwerpen
Antwerpen , 2060, Belgium
Cliniques Universitaires Saint Luc
Brussels , 1200, Belgium
Universitair Ziekenhuis Gent
Ghent , 9000, Belgium
Universitaire Ziekenhuis Gasthuisberg
Leuven , 3000, Belgium
Tom Baker Cancer Centre
Calgary Alberta, T2N 2, Canada
Cross Cancer Institute
Edmonton Alberta, T6G 1, Canada
Cancer Care Manitoba
Winnipeg Manitoba, R3E 0, Canada
Hopital Regional De Sudbury Regional Hospital (HRSRH) - Regional Cancer Program (RCP)
Sudbury Ontario, P3E 5, Canada
Centre Hospitalier Universitaire de Montréal
Montréal Quebec, H1T 2, Canada
Centre Hospitalier Regional de Rimouski
Rimouski Quebec, G5L 5, Canada
Saskatchewan Cancer Agency
Regina Saskatchewan, S4T 1, Canada
Cancer Care Manitoba
Winnipeg , R3E 0, Canada
Aalborg Hospital
Aalborg , 9100, Denmark
Aarhus University Hospital
Ã…rhus , 8000, Denmark
Center Hospitalier Universitaire de Bordeaux
Pessac Cedex Aquitaine, 33604, France
Hôpital Saint Louis
Paris Cedex 10 Ile-de-france, 75010, France
Centre Hospitalier de Perpignan
Perpignan Languedoc-Roussillon, 66046, France
Centre Hospitalier Universitaire Nancy
Vandoeuvre Limousin, Lorraine, 54511, France
Centre Hospitalier Universitaire Purpan
Toulouse Cedex Midi-pyrenees, 31059, France
CHRU Clermont- Ferrand CHU Estaing
Auvergne , 63000, France
Centre Hospitalier Universitaire Hôpital Avicenne
Ile-de-france , 93009, France
University College Cork
Cork , , Ireland
Saint James's Hospital
Dublin , 8, Ireland
Collegium Medicum Uniwersytetu Jagiellonskiego w K
Kraków Malopolskie, 31-50, Poland
Wojewódzki Szpital Specjalistyczny im. Janusza Kor
Slupsk Pomorskie, 76-20, Poland
Szpital Specjalistyczny w Brzozowie
Brzozow , 36-20, Poland
Wojewódzki Szpital Specjalistyczny im. Mikolaja Kopernika w Lodzi
Lódz , 93-51, Poland
Centralny Szpital Kliniczny MSW
Warszawa , 02-50, Poland
Samodzielny Publiczny Szpital Kliniczny N1 Klinika
Wroclaw , 50-36, Poland
Hospital Clínic i Provincial
Barcelona , 08025, Spain
Hospital Vall d´Hebrón
Barcelona , 08035, Spain
Hospital Universitario La Princesa
Madrid , 28006, Spain
Hospital Universitario 12 de Octubre
Madrid , 28041, Spain
Hospital Puerta de Hierro Majadahonda
Madrid , 28222, Spain
Hospital Morales Meseguer
Murcia , 30008, Spain
Sunderby Sjukhus
Luleå , 971 8, Sweden
Karolinska University Hospital Solna
Stockholm , 171 6, Sweden
Karolinska University Hospital Huddinge
Stockholm , 171 7, Sweden
Birmingham Heartlands Hospital
Birmingham England, B9 5S, United Kingdom
Darent Valley Hospital
Dartford England, DA2 8, United Kingdom
Royal Surrey County Hospital NHS Trust
Guildford England, GU2 7, United Kingdom
Haematology and Transplant Unit
Manchester England, M20 4, United Kingdom
Norfolk and Norwich University Hospital
Norwich Norfolk, NR4 7, United Kingdom
Saint James's University Hospital
Leeds , LS9 7, United Kingdom
University College London
London , NW1 2, United Kingdom
University College London
London , WC1E , United Kingdom
Department of Haematology, Cancer and Haematology Centre, Churchill Hospital (Oxford University Hospitals)
Oxford , OX3 7, United Kingdom

How clear is this clinincal trial information?

Study is for people with:

Chronic Lymphocytic Leukemia

Phase:

Phase 3

Estimated Enrollment:

261

Study ID:

NCT01659021

Recruitment Status:

Terminated

Sponsor:


Gilead Sciences

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider